1 Division of Hematology & Oncology, Department of Medicine, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
2 Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Palliat Med. 2018 Apr;32(4):757-766. doi: 10.1177/0269216317751893. Epub 2018 Jan 11.
Early palliative care interventions enhance patient outcomes, including quality of life, mood, and coping, but it remains unclear whether certain subgroups of patients are more likely to benefit from early palliative care. We explored whether age and sex moderate the improved outcomes seen with early palliative care.
We performed a secondary analysis of data from a randomized trial of 350 patients with advanced lung and non-colorectal gastrointestinal cancer. Patients received an early palliative care intervention integrated with oncology care or usual oncology care alone. We used linear regression to determine if age (older or younger than 65) and sex moderated the effects of the intervention on quality of life (Functional Assessment of Cancer Therapy-General (FACT-G)), depression symptoms (Patient Health Questionnaire 9 (PHQ-9)), and coping (Brief COPE) within lung and gastrointestinal subgroups.
At 24 weeks, younger patients with lung cancer receiving early palliative care reported increased use of active coping ( B = 1.74; p = 0.02) and decreased use of avoidant coping ( B = -0.97; p = 0.02), but the effects of early palliative care on these outcomes were not significant for older patients. Male patients with lung cancer assigned to early palliative care reported better quality of life (FACT-G: B = 9.31; p = 0.01) and lower depression scores (PHQ-9: B = -2.82; p = 0.02), but the effects of early palliative care on these outcomes were not significant for female patients. At 24 weeks, we found no age or sex moderation effects within the gastrointestinal cancer subgroup.
Age and sex moderate the effects of early palliative care for patients with advanced lung cancer. Early palliative care may need to be tailored to individuals' unique sociodemographic and clinical characteristics.
早期姑息治疗干预可改善患者的预后,包括生活质量、情绪和应对能力,但目前尚不清楚哪些特定的患者亚组更可能从早期姑息治疗中获益。我们探讨了年龄和性别是否调节了早期姑息治疗所带来的改善结局。
我们对一项针对 350 例晚期肺癌和非结直肠胃肠道癌患者的随机试验数据进行了二次分析。患者接受了早期姑息治疗干预,该干预与肿瘤学治疗相结合,或仅接受常规肿瘤学治疗。我们使用线性回归来确定年龄(65 岁以上或以下)和性别是否调节了干预对肺癌和胃肠道亚组中生活质量(癌症治疗功能评估一般量表(FACT-G))、抑郁症状(患者健康问卷 9 项(PHQ-9))和应对方式(简短应对方式量表(Brief COPE))的影响。
在 24 周时,接受早期姑息治疗的年轻肺癌患者报告采用了更多的积极应对方式(B=1.74;p=0.02),回避应对方式减少(B=-0.97;p=0.02),但这些结局的早期姑息治疗效果在老年患者中并不显著。被分配到早期姑息治疗的男性肺癌患者报告生活质量(FACT-G:B=9.31;p=0.01)和抑郁评分(PHQ-9:B=-2.82;p=0.02)更好,但女性患者的早期姑息治疗效果并不显著。在 24 周时,我们未在胃肠道癌症亚组中发现年龄或性别调节作用。
年龄和性别调节了晚期肺癌患者接受早期姑息治疗的效果。早期姑息治疗可能需要根据个体独特的社会人口学和临床特征进行调整。